Recent progress and concerns regarding the Japanese immunization program: Addressing the “vaccine gap”

Highlights • Seven new vaccines (12 products) have been introduced in Japan since 2008. • The Japanese Immunization Law underwent major revision in 2013. • A recent rubella epidemic in Japan led to >40 cases of congenital rubella syndrome. • The HPV vaccine was temporarily withdrawn due to report...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2014-07, Vol.32 (34), p.4253-4258
Hauptverfasser:	Saitoh, Akihiko, Okabe, Nobuhiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Allergy and Immunology Applied microbiology Biological and medical sciences Budgets Chronic Pain - chemically induced Congenital rubella syndrome Conversion disorder Developed countries Epidemics Fundamental and applied biological sciences. Psychology Health Policy Human papilloma virus vaccine Human viral diseases Humans Immunization Immunization program Immunization Programs - legislation & jurisprudence Immunization Programs - organization & administration Industrialized nations Infectious diseases Japan Licenses Medical sciences Microbiology Papillomavirus Vaccines - adverse effects Public health Rubella Rubella - epidemiology Safety-Based Drug Withdrawals Tetanus Tuberculosis Tumors Vaccine gap Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Viral diseases Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye Viruses Whooping cough
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • Seven new vaccines (12 products) have been introduced in Japan since 2008. • The Japanese Immunization Law underwent major revision in 2013. • A recent rubella epidemic in Japan led to >40 cases of congenital rubella syndrome. • The HPV vaccine was temporarily withdrawn due to reports of pain/motor impairment. • Some important vaccines are still categorized as voluntary vaccines in Japan.
ISSN:	0264-410X 1873-2518
DOI:	10.1016/j.vaccine.2014.06.022